2023
1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study
HAIDER S, PARKER M, HUANG E, GRANT R, MOFFET H, LAITEERAPONG N, LIU J, LIPSKA K, KARTER A. 1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study. Diabetes 2023, 72 DOI: 10.2337/db23-1217-p.Peer-Reviewed Original ResearchType 2 diabetesOlder patientsKaiser Permanente Northern CaliforniaDe-intensify treatmentDuration of diabetesGlucose-lowering medicationsNumber of medicationsProportion of patientsClinical guideline recommendationsHealth status factorsPoor health statusCross-sectional analysisInsulin useComplex regimensLess medicationGuideline recommendationsPatients' willingnessAbbVie Inc.Side effectsDiabetesPatient experiencePatientsHealth statusHypoglycemia historyMedications
2021
864-P: Treatment Burden and Quality of Life Conversations during Clinical Encounters: A Videographic Analysis
HAIDER S, EL KAWKGI O, CLARK J, BRESLIN M, BOEHMER K, MONTORI V, LIPSKA K. 864-P: Treatment Burden and Quality of Life Conversations during Clinical Encounters: A Videographic Analysis. Diabetes 2021, 70 DOI: 10.2337/db21-864-p.Peer-Reviewed Original ResearchTreatment burdenDiabetes mellitusSexual functionDiagnosis of DMClinical encountersSocial supportInternal medicine clinicPatient-clinician encountersClinician-patient encountersQuality of lifeCommon complicationDiabetes careMedicine clinicSexual dysfunctionPatient concernsPatient experienceSignificant burdenHypoglycemiaQoLProvider responsesPatientsVideographic analysisLife conversationsFamily medicineClinicians